This is typically the case with MSCs, if anyone has done any research into previous companies developing these sorts of therapies they'd have known phase 3 trials rarely succeed.
Ann: Mesoblast Update on COVID-19 ARDS Trial, page-70
-
- There are more pages in this discussion • 1,006 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
0.000(0.00%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 539 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 10643 | 1 |
View Market Depth
| Last trade - 09.52am 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable